Though artificial bioactive compounds are permitted in lots of nations for meals functions, they’re changing into much less and fewer welcome by customers. Due to this fact, there was an growing curiosity in changing these artificial compounds by pure bioactive compounds. These pure compounds can be utilized as meals components to take care of the meals high quality, meals security and attraction, and as meals dietary supplements or nutraceuticals to right dietary deficiencies, keep an appropriate consumption of vitamins, or to assist physiological capabilities, respectively.
Latest research reveal that quite a few meals wastes, significantly fruit and greens byproducts, are a very good supply of bioactive compounds that may be extracted and reintroduced into the meals chain as pure meals components or in meals matrices for acquiring nutraceuticals and purposeful meals. This evaluation addresses common questions regarding using fruit and greens byproducts as new sources of pure bioactive compounds which can be being addressed to meals as pure components and dietary supplements. These bioactive compounds should observe the authorized necessities and evaluations to evaluate the dangers for human well being and their toxicity should be thought-about earlier than being launched into the market.
To beat the potential well being danger whereas growing the organic exercise, stability and biodistribution of the dietary supplements’ technological options have been studied comparable to encapsulation of bioactive compounds into micro or nanoparticles or nanoemulsions. It will permit enhancing the soundness and launch alongside the gastrointestinal tract in a managed method into the precise tissues. This evaluation summarizes the valorization path {that a} bioactive compound recovered from an agro-food waste can face from the second their potentialities are exhibited till it reaches the ultimate client and the protection and toxicity challenges, they could overcome.
Preclinical Bioavailability, Tissue Distribution, and Protein Binding Research of Erinacine A, a Bioactive Compound from Hericium erinaceus Mycelia Utilizing Validated LC-MS/MS Methodology
Erinacine A, derived from the mycelia of Hericium erinaceus, has attracted a lot consideration because of its neuroprotective properties. Nevertheless, only a few research have been carried out on the bioavailability, tissue distribution, and protein binding of erinacine A. This research aimed to analyze the bioavailability, tissue distribution, and protein binding of erinacine A in Sprague-Dawley rats. After oral administration (po) and intravenous administration (iv) of two.381 g/kg BW of the H. erinaceus mycelia extract (equal to 50 mg/kg BW of erinacine A) and 5 mg/kg BW of erinacine A, respectively, absolutely the bioavailability of erinacine A was estimated as 24.39%.
Erinacine A was detected in mind at 1 h after oral dosing and reached the height at eight h. Protein binding assay confirmed unbound erinacine A fractions in mind to blood ratio is near unity, supporting passive diffusion because the dominating transport. Feces was the foremost route for the elimination of erinacine A. This research is the primary to indicate that erinacine A can penetrate the blood-brain barrier of rats by the technique of passive diffusion and thus assist the event of H. erinaceus mycelia for the development of neurohealth.
Enzymatic pretreatment of seeds is a novel method that enhances the well being advantages of the extracted oil. The research investigated the affect of the enzymatic pretreatment of seeds on the standard of oil from totally different pomegranate cultivars. The standard of the ultrasound-assisted (and ethanol-extracted) oil was studied, with respect to the refractive index (RI), yellowness index (YI), conjugated dienes (Ok232), peroxide worth (PV) ρ-anisidine worth (AV), whole oxidation worth (TOTOX), whole carotenoid content material (TCC), whole phenolic compounds (TPC), fatty acid composition, phytosterol composition, ferric lowering antioxidant energy (FRAP), and a pair of.2-diphenyl-1-picryl hydrazyl (DPPH) radical scavenging capability.
Dedication of Bioactive Compounds in Sequential Extracts of Chia Leaf ( Salvia hispanica L.) Utilizing UHPLC-HRMS (Q-Orbitrap) and a World Analysis of Antioxidant In Vitro Capability
Shoppers’ curiosity in meals which can be nutritionally balanced and with well being advantages has elevated. The meals trade is being attentive to using the ancestral seed Salvia hispanica L., generally often known as chia. At current, solely chia seeds, that are a pure supply of omega-Three and omega-6, fiber, proteins, and pure antioxidants, are commercialized. Though some research reveal the presence of a number of bioactive compounds, comparable to polyphenols (e.g., vitexin, orientin, and a few hydroxycinnamic acids) in chia leaf methanolic extracts, the chia plant is usually used as fertilizer or handled as waste after harvest.
Due to this fact, it might symbolize a by-product that may very well be thought-about an incredible supply of bioactive compounds with unexplored potential in medication and meals trade functions. On this work, UHPLC-HRMS (Q-Orbitrap) was employed to tentatively determine and decide the bioactive compounds current in numerous leaf extracts of chia crops of black and white seed phenotype obtained with solvents of various polarity (ethanol, ethyl acetate, dichloromethane, and hexane) to handle chia plant by-product revalorization. The chemical antioxidant capability was additionally studied and correlated to the discovered bioactive compounds.
Recombinant Human UPF0670 protein C8orf55 (C8orf55) |
|||
| MBS1305772-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 830 |
Recombinant Human UPF0670 protein C8orf55 (C8orf55) |
|||
| MBS1305772-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1010 |
THEM6 / C8orf55 Rabbit Polyclonal (N-Terminus) Antibody |
|||
| TA317416 | Origene Technologies GmbH | 50 µg | Ask for price |
Human UPF0670 protein C8orf55, C8orf55 ELISA KIT |
|||
| ELI-50017h | Nova Lifetech | 96tests | EUR 696 |
Human UPF0670 protein C8orf55, C8orf55 ELISA Kit |
|||
| MBS9327447-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Human UPF0670 protein C8orf55, C8orf55 ELISA Kit |
|||
| MBS9327447-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Human UPF0670 protein C8orf55, C8orf55 ELISA Kit |
|||
| MBS9327447-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Human UPF0670 protein C8orf55, C8orf55 ELISA Kit |
|||
| MBS9327447-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55, UPF0670 Protein C8orf55, PSEC0098) |
|||
| MBS642214-01mg | MyBiosource | 0.1mg | EUR 615 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55, UPF0670 Protein C8orf55, PSEC0098) |
|||
| MBS642214-5x01mg | MyBiosource | 5x0.1mg | EUR 2605 |
C8orf55 Recombinant Protein (Human) |
|||
| RP050179 | ABM | 100 ug | Ask for price |
C8orf55 ORF Vector (Human) (pORF) |
|||
| ORF016727 | ABM | 1.0 ug DNA | EUR 486 |
C8orf55 Over-expression Lysate Product |
|||
| GWB-537C2B | GenWay Biotech | 0.1 mg | Ask for price |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS243020-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS243020-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS243558-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS243558-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS246823-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS246823-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS247168-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit Polyclonal to Human THEM6 / C8orf55 |
|||
| MBS247168-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
C8orf55 sgRNA CRISPR Lentivector set (Human) |
|||
| K0261501 | ABM | 3 x 1.0 ug | EUR 406.8 |
C8orf55 (THEM6) (NM_016647) Human Recombinant Protein |
|||
| PROTQ8WUY1 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human chromosome 8 open reading frame 55 (C8orf55) |
|||
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6004312-005mg | MyBiosource | 0.05(mg | EUR 745 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6004312-5x005mg | MyBiosource | 5x0.05mg | EUR 3195 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6012322-005mg | MyBiosource | 0.05(mg | EUR 745 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6012322-5x005mg | MyBiosource | 5x0.05mg | EUR 3195 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6010094-005mg | MyBiosource | 0.05(mg | EUR 745 |
Mesenchymal Stem Cell Protein DSCD75 (C8orf55) |
|||
| MBS6010094-5x005mg | MyBiosource | 5x0.05mg | EUR 3195 |
Recombinant Rat UPF0670 protein C8orf55 homolog |
|||
| MBS1480088-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1105 |
Recombinant Rat UPF0670 protein C8orf55 homolog |
|||
| MBS1480088-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 700 |
Recombinant Rat UPF0670 protein C8orf55 homolog |
|||
| MBS1480088-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 860 |
Recombinant Rat UPF0670 protein C8orf55 homolog |
|||
| MBS1480088-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 820 |
Recombinant Rat UPF0670 protein C8orf55 homolog |
|||
| MBS1480088-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1005 |
Recombinant Mouse UPF0670 protein C8orf55 homolog |
|||
| MBS1299635-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1105 |
Recombinant Mouse UPF0670 protein C8orf55 homolog |
|||
| MBS1299635-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 700 |
Recombinant Mouse UPF0670 protein C8orf55 homolog |
|||
| MBS1299635-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 860 |
Recombinant Mouse UPF0670 protein C8orf55 homolog |
|||
| MBS1299635-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 820 |
Recombinant Mouse UPF0670 protein C8orf55 homolog |
|||
| MBS1299635-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1005 |
Recombinant Bovine UPF0670 protein C8orf55 homolog |
|||
| MBS1045547-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1105 |
Recombinant Bovine UPF0670 protein C8orf55 homolog |
|||
| MBS1045547-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 700 |
Recombinant Bovine UPF0670 protein C8orf55 homolog |
|||
| MBS1045547-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 860 |
Recombinant Bovine UPF0670 protein C8orf55 homolog |
|||
| MBS1045547-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 820 |
Recombinant Bovine UPF0670 protein C8orf55 homolog |
|||
| MBS1045547-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1005 |
C8orf55 3'UTR GFP Stable Cell Line |
|||
| TU052535 | ABM | 1.0 ml | EUR 1672.8 |
C8orf55 Protein Vector (Human) (pPM-C-HA) |
|||
| PV066907 | ABM | 500 ng | EUR 662.4 |
C8orf55 3'UTR Luciferase Stable Cell Line |
|||
| TU002535 | ABM | 1.0 ml | EUR 1672.8 |
C8orf55 Protein Vector (Human) (pPB-C-His) |
|||
| PV066905 | ABM | 500 ng | EUR 662.4 |
C8orf55 Protein Vector (Human) (pPB-N-His) |
|||
| PV066906 | ABM | 500 ng | EUR 662.4 |
C8orf55 Protein Vector (Human) (pPM-C-His) |
|||
| PV066908 | ABM | 500 ng | EUR 662.4 |
C8orf55 (THEM6) (NM_016647) Human Over-expression Lysate |
|||
| LS051337 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of chromosome 8 open reading frame 55 (C8orf55) |
|||
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0261502 | ABM | 1.0 ug DNA | EUR 184.8 |
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0261503 | ABM | 1.0 ug DNA | EUR 184.8 |
C8orf55 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0261504 | ABM | 1.0 ug DNA | EUR 184.8 |
Recombinant Xenopus laevis UPF0670 protein C8orf55 homolog |
|||
| MBS1387479-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1100 |
Recombinant Xenopus laevis UPF0670 protein C8orf55 homolog |
|||
| MBS1387479-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 695 |
Recombinant Xenopus laevis UPF0670 protein C8orf55 homolog |
|||
| MBS1387479-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 855 |
Recombinant Xenopus laevis UPF0670 protein C8orf55 homolog |
|||
| MBS1387479-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 810 |
Recombinant Xenopus laevis UPF0670 protein C8orf55 homolog |
|||
| MBS1387479-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1000 |
Recombinant Xenopus tropicalis UPF0670 protein C8orf55 homolog |
|||
| MBS1050020-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1100 |
Recombinant Xenopus tropicalis UPF0670 protein C8orf55 homolog |
|||
| MBS1050020-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 695 |
Recombinant Xenopus tropicalis UPF0670 protein C8orf55 homolog |
|||
| MBS1050020-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 855 |
Recombinant Xenopus tropicalis UPF0670 protein C8orf55 homolog |
|||
| MBS1050020-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 810 |
Recombinant Xenopus tropicalis UPF0670 protein C8orf55 homolog |
|||
| MBS1050020-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1000 |
Recombinant Danio rerio UPF0670 protein C8orf55 homolog (si:ch73-52e5.2) |
|||
| MBS1229131-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1100 |
Recombinant Danio rerio UPF0670 protein C8orf55 homolog (si:ch73-52e5.2) |
|||
| MBS1229131-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 695 |
Recombinant Danio rerio UPF0670 protein C8orf55 homolog (si:ch73-52e5.2) |
|||
| MBS1229131-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 850 |
Recombinant Danio rerio UPF0670 protein C8orf55 homolog (si:ch73-52e5.2) |
|||
| MBS1229131-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 805 |
Recombinant Danio rerio UPF0670 protein C8orf55 homolog (si:ch73-52e5.2) |
|||
| MBS1229131-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 995 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0261505 | ABM | 3 x 1.0 ug | EUR 451.2 |
THEM6 (untagged)-Human chromosome 8 open reading frame 55 (C8orf55) |
|||
| SC323787 | Origene Technologies GmbH | 10 µg | Ask for price |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0261506 | ABM | 1.0 ug DNA | EUR 200.4 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0261507 | ABM | 1.0 ug DNA | EUR 200.4 |
C8orf55 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0261508 | ABM | 1.0 ug DNA | EUR 200.4 |
THEM6 (GFP-tagged) - Human chromosome 8 open reading frame 55 (C8orf55) |
|||
| RG201709 | Origene Technologies GmbH | 10 µg | Ask for price |
THEM6 (Myc-DDK-tagged)-Human chromosome 8 open reading frame 55 (C8orf55) |
|||
| RC201709 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human chromosome 8 open reading frame 55 (C8orf55), mGFP tagged |
|||
| RC201709L4 | Origene Technologies GmbH | 10 µg | Ask for price |
C5orf26 (C5orf26) Antibody |
|||
| abx231120-100ug | Abbexa | 100 ug | EUR 577.2 |
C9orf117 Antibody |
|||
| abx122983-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf161 Antibody |
|||
| abx146255-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf156 Antibody |
|||
| abx146257-100ug | Abbexa | 100 ug | EUR 469.2 |
C1orf111 Antibody |
|||
| abx146267-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf168 Antibody |
|||
| abx146370-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf211 Antibody |
|||
| abx146371-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf106 Antibody |
|||
| abx146379-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf118 Antibody |
|||
| abx146394-100ug | Abbexa | 100 ug | EUR 469.2 |
C6orf190 Antibody |
|||
| abx146395-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf156 Antibody |
|||
| abx146414-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf114 Antibody |
|||
| abx146415-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf102 Antibody |
|||
| abx146425-100ug | Abbexa | 100 ug | EUR 469.2 |
C9orf156 Antibody |
|||
| 20-abx149327 | Abbexa |
|
|
C9orf156 Antibody |
|||
| abx033079-400ul | Abbexa | 400 ul | EUR 627.6 |
C9orf156 Antibody |
|||
| abx033079-80l | Abbexa | 80 µl | EUR 343.2 |
C9orf156 Antibody |
|||
| 20-abx002463 | Abbexa |
|
|
C6orf138 Antibody |
|||
| abx026241-400ul | Abbexa | 400 ul | EUR 627.6 |
C6orf138 Antibody |
|||
| abx026241-80l | Abbexa | 80 µl | EUR 343.2 |
C6orf211 Antibody |
|||
| abx028716-400ul | Abbexa | 400 ul | EUR 627.6 |
C6orf211 Antibody |
|||
| abx028716-80l | Abbexa | 80 µl | EUR 343.2 |
C6orf210 antibody |
|||
| 22198 | SAB | 100ul | EUR 479 |
C6orf210 antibody |
|||
| 22198-100ul | SAB | 100ul | EUR 468 |
C1orf165 antibody |
|||
| 23150 | SAB | 100ul | EUR 479 |
C1orf165 antibody |
|||
| 23150-100ul | SAB | 100ul | EUR 468 |
C1orf112 antibody |
|||
| 31835-100ul | SAB | 100ul | EUR 302.4 |
C1orf112 antibody |
|||
| 31835-50ul | SAB | 50ul | EUR 224.4 |
C9orf116 Antibody |
|||
| 47264 | SAB | 100ul | EUR 319 |
C9orf116 Antibody |
|||
| 47264-100ul | SAB | 100ul | EUR 302.4 |
C1orf175 Antibody |
|||
| 48086-100ul | SAB | 100ul | EUR 399.6 |
C1orf175 Antibody |
|||
| 48086-50ul | SAB | 50ul | EUR 286.8 |
C1orf101 Antibody |
|||
| 46367 | SAB | 100ul | EUR 319 |
C1orf101 Antibody |
|||
| 46367-100ul | SAB | 100ul | EUR 302.4 |
C1orf106 Antibody |
|||
| 46368 | SAB | 100ul | EUR 319 |
C1orf106 Antibody |
|||
| 46368-100ul | SAB | 100ul | EUR 302.4 |
C9orf156 Antibody |
|||
| 44873-100ul | SAB | 100ul | EUR 302.4 |
C9orf156 Antibody |
|||
| 44873-50ul | SAB | 50ul | EUR 224.4 |
C1orf103 Antibody |
|||
| abx231057-100ug | Abbexa | 100 ug | EUR 610.8 |
C1orf104 Antibody |
|||
| abx231058-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf156 Antibody |
|||
| abx231061-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf163 Antibody |
|||
| abx231062-100ug | Abbexa | 100 ug | EUR 610.8 |
C6orf130 Antibody |
|||
| abx231124-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf173 Antibody |
|||
| abx231127-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf182 Antibody |
|||
| abx231128-100ug | Abbexa | 100 ug | EUR 610.8 |
C6orf204 Antibody |
|||
| abx231129-100ug | Abbexa | 100 ug | EUR 577.2 |
C6orf211 Antibody |
|||
| abx231130-100ug | Abbexa | 100 ug | EUR 577.2 |
C9orf156 Antibody |
|||
| abx231143-100ug | Abbexa | 100 ug | EUR 577.2 |
C1orf189 Antibody |
|||
| 20-abx301998 | Abbexa |
|
|
C6orf223 Antibody |
|||
| 20-abx301118 | Abbexa |
|
|
C9orf163 Antibody |
|||
| 20-abx301522 | Abbexa |
|
|
C1orf127 Antibody |
|||
| 20-abx301622 | Abbexa |
|
|
C1orf158 Antibody |
|||
| 20-abx309398 | Abbexa |
|
|
C6orf136 Antibody |
|||
| 20-abx307509 | Abbexa |
|
|
C1orf111 Antibody |
|||
| 20-abx307539 | Abbexa |
|
|
C1orf210 Antibody |
|||
| 20-abx308482 | Abbexa |
|
|
C1orf123 Antibody |
|||
| 20-abx318425 | Abbexa |
|
|
C1orf210 Antibody |
|||
| 1-CSB-PA808993LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf210. Recognizes C1orf210 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
C9orf163 Antibody |
|||
| 1-CSB-PA822739LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C9orf163. Recognizes C9orf163 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf112 Antibody |
|||
| 1-CSB-PA878881LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf112. Recognizes C1orf112 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf127 Antibody |
|||
| 1-CSB-PA854077LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf127. Recognizes C1orf127 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C1orf101 Antibody |
|||
| E046367 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C1orf106 Antibody |
|||
| E046368 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C9orf116 Antibody |
|||
| E047264 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C6orf203 Antibody |
|||
| 1-CSB-PA889170LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf203. Recognizes C6orf203 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
C6orf223 Antibody |
|||
| 1-CSB-PA836654LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C6orf223. Recognizes C6orf223 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
C1orf158 Antibody |
|||
| 1-CSB-PA839778LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf158. Recognizes C1orf158 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
C1orf123 Antibody |
|||
| 1-CSB-PA873673LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against C1orf123. Recognizes C1orf123 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
C9orf142 Antibody |
|||
| DF13585 | Affbiotech | 100ul | EUR 420 |
C9orf142 Antibody |
|||
| DF13585-100ul | Affinity Biosciences | 100ul | EUR 280 |
C9orf142 Antibody |
|||
| DF13585-200ul | Affinity Biosciences | 200ul | EUR 350 |
C1orf114 Antibody |
|||
| DF14271 | Affbiotech | 100ul | EUR 420 |
C1orf114 Antibody |
|||
| DF14271-100ul | Affinity Biosciences | 100ul | EUR 280 |
C1orf114 Antibody |
|||
| DF14271-200ul | Affinity Biosciences | 200ul | EUR 350 |
C1orf198 Antibody |
|||
| DF15087 | Affbiotech | 100ul | EUR 420 |
C1orf198 Antibody |
|||
| DF15087-100ul | Affinity Biosciences | 100ul | EUR 280 |
C1orf198 Antibody |
|||
| DF15087-200ul | Affinity Biosciences | 200ul | EUR 350 |
C1orf163 Antibody |
|||
| DF12866 | Affbiotech | 200ul | EUR 420 |
C1orf163 Antibody |
|||
| DF12866-100ul | Affinity Biosciences | 100ul | EUR 280 |
C1orf163 Antibody |
|||
| DF12866-200ul | Affinity Biosciences | 200ul | EUR 350 |
C6orf150 Antibody |
|||
| DF12574 | Affbiotech | 200ul | EUR 420 |
C6orf150 Antibody |
|||
| DF12574-100ul | Affinity Biosciences | 100ul | EUR 280 |
C6orf150 Antibody |
|||
| DF12574-200ul | Affinity Biosciences | 200ul | EUR 350 |
C6orf134 Antibody |
|||
| DF13487 | Affbiotech | 100ul | EUR 420 |
C6orf134 Antibody |
|||
| DF13487-100ul | Affinity Biosciences | 100ul | EUR 280 |
C6orf134 Antibody |
|||
| DF13487-200ul | Affinity Biosciences | 200ul | EUR 350 |
C9orf156 Antibody |
|||
| DF2619 | Affbiotech | 200ul | EUR 420 |
C9orf156 Antibody |
|||
| DF2619-100ul | Affinity Biosciences | 100ul | EUR 280 |
C9orf156 Antibody |
|||
| DF2619-200ul | Affinity Biosciences | 200ul | EUR 350 |
C1orf100 Antibody |
|||
| E40PV5399 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf122 Antibody |
|||
| E40PV5400 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf159 Antibody |
|||
| E40PV5402 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf162 Antibody |
|||
| E40PV5403 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf226 Antibody |
|||
| E40PV5409 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf229 Antibody |
|||
| E40PV5411 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C6orf223 Antibody |
|||
| E40PV5957 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C9orf153 Antibody |
|||
| E40PV6032 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf141 Antibody |
|||
| E40PV622 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf167 Antibody |
|||
| E40PV624 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf194 Antibody |
|||
| E40PV625 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C9orf135 Antibody |
|||
| E40PV855 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C9orf163 Antibody |
|||
| E40PV856 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C1orf156 antibody |
|||
| E39-01061 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
C1orf146 Antibody |
|||
| E40P12132 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
C9orf156 Antibody |
|||
| E93434 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C1orf106 Antibody |
|||
| E93460 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C1orf116 Antibody |
|||
| E94959 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
C1orf109 Antibody |
|||
| E312136 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
C9orf125 Antibody |
|||
| E312345 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
C1orf124 Antibody |
|||
| E313130 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
C1orf123 antibody |
|||
| E313729 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
C1orf210 antibody |
|||
| E313749 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
In these experiments, black chia confirmed the next antioxidant capability than white chia within the ethanolic extracts. Furthermore, experiments on mobile antioxidant exercise have been additionally carried out with a predominance of the white chia extract. It’s famous that the mobile antioxidant exercise outcomes make chia ethanolic extracts promising antioxidants.